Alzheimer's disease is a progressive neurodegenerative disorder that affects an estimated 35.6 million people worldwide, according to the World Health Organization. While there is no cure for Alzheimer's, several treatments are currently being investigated to slow its progression and improve symptoms.
Beta-secretase inhibitors are a type of drug that blocks the action of an enzyme called beta-secretase, which is involved in the formation of amyloid plaques - a hallmark of Alzheimer's disease. These drugs are currently being investigated as a potential treatment for Alzheimer's, although clinical trials have had mixed results so far.
Beta-secretase inhibitors are a type of drug that blocks the action of an enzyme called beta-secretase, which is involved in the formation of amyloid plaques - a hallmark of Alzheimer's disease. These drugs are currently being investigated as a potential treatment for Alzheimer's, although clinical trials have had mixed results so far.
Tau PET imaging agents are compounds that can be used to detect tau protein in the brain, which is another hallmark of Alzheimer's disease. These agents are being investigated as a potential tool for diagnosing and tracking the progression of Alzheimer's, as well as for identifying potential treatment targets.
Nicotinamide mononucleotide is a compound that occurs naturally in the body and has been shown to have anti-aging effects in various animal models. Preliminary clinical trials suggest that NMN may also be effective in slowing the progression of Alzheimer's disease, although more research is needed to confirm these findings.
Sirtuins are a family of enzymes that have been shown to have anti-aging effects in various cellular models. Some compounds that modulate sirtuin activity are being investigated as potential treatments for Alzheimer's disease, although more research is needed to determine their effectiveness.
Immunotherapy is a type of treatment that involves stimulating the immune system to attack specific proteins or cells in the body. Some researchers are investigating whether immunotherapy could be effective in treating Alzheimer's disease by targeting the beta-amyloid protein or other harmful substances in the brain.
While there is no cure for Alzheimer's disease, several promising treatments are currently being investigated that may slow its progression and improve symptoms. Further research is needed to determine the effectiveness of these treatments and to develop new therapies that can halt or reverse the disease process.
